全球活檢設備市場 - 市場規模（按細分市場）、份額、監管、報銷、程序、預測（~2033 年）

全球癌症發生率的增加是活檢設備市場的主要驅動因素之一。 患病率的不斷增加增加了對有效診斷治療的需求並影響了市場成長。 對微創手術的需求也促進了活檢設備市場的發展。 技術的進步，特別是具有改進功能的活檢設備，例如更高的準確性、更快的患者復健和微創手術，可以帶來更安全的手術。 促進診斷的政府計劃預計將提高診斷設備的使用率。

本報告研究和分析了全球活檢設備市場，並提供了有關每個細分市場的市場規模、市場趨勢、競爭格局以及 COVID-19 影響的資訊。

市場模型的主要內容如下。

商用切片設備和不斷變化的競爭格局

• 對主要產業趨勢的考慮
• 按活檢設備市場細分的年收入和市場前景（2015-2033 年）
• 按細分市場劃分的手術總數、單位數量、平均售價和市場價值的詳細數據

全球、區域和國家層面的特定市場考量

• 按地區細分全球趨勢的特定市場定性資訊和國家/地區考慮因素
• 切片設備市場的SWOT分析
• 切片設備市場競爭動態的考量與趨勢

透過對醫療保健系統的真實、全面的了解來促進市場了解。 市場進入部分還提供有關報銷政策和監管環境的信息，使您能夠更深入地研究市場動態。

• 各國醫療保健系統概覽
• 按國家/地區劃分的報銷政策
• 各國醫療科技監理狀況

目標公司

• Becton Dickinson and Co
• Danaher Corp
• Hologic Inc
• Cook Group Inc
• Boston Scientific Corp
• Medtronic Plc
• ConMed Corp
• Olympus Corp
• Weigao Group Co Ltd
• Henry Schein Inc
• Coloplast A/S
• Merit Medical Systems Inc
• Integra LifeSciences Holdings Corp
• Teleflex Inc
• Acuderm Inc
• Steris Plc
• 其他

Abstract

Biopsy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within General Surgery Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Biopsy Devices market for the year 2020 and beyond. A biopsy device is an instrument that aids in the removal of tissue samples from the body. Increasing global cancer incidence is one of the primary drivers of the biopsy devices market. Increasing prevalence results in a growing need for effective diagnostic procedures, which in turn, impacts market growth. Demand for the minimal invasive procedure has also contributed to the biopsy devices market. Advances in technology, especially biopsy devices with improved features such as enhanced accuracy, quicker recovery of patients, and less traumatic procedures, will result in safer procedures. Government programs to promote diagnosis is expected to improve the utilization of diagnostic devices.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Biopsy Devices and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Biopsy Devices market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Biopsy Devices market.
• Competitive dynamics insights and trends provided for Biopsy Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Becton Dickinson and Co, Danaher Corp, Hologic Inc, Cook Group Inc, Boston Scientific Corp, Medtronic Plc, ConMed Corp, Olympus Corp, Weigao Group Co Ltd, Henry Schein Inc, Coloplast A/S, Merit Medical Systems Inc, Integra LifeSciences Holdings Corp, Teleflex Inc, Acuderm Inc, Steris Plc, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Biopsy Devices marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Biopsy Devices market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Biopsy Devices market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Biopsy Devices market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Biopsy Devices market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable

List of Tables

Not Applicable

List of Figures

Not Applicable